<DOC>
	<DOCNO>NCT02254044</DOCNO>
	<brief_summary>maximum tolerate dose ( MTD ) , safety , pharmacokinetics , efficacy bivatuzumab mertansine</brief_summary>
	<brief_title>Dose Escalation Bivatuzumab Mertansine Patients With Advanced Squamous Cell Carcinoma Head Neck Esophagus</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Maytansine</mesh_term>
	<criteria>1. patient 18 80 year age ( inclusive ) 2. patient histologically confirm squamous cell carcinoma head neck esophagus 3. patient local / regional recurrent disease distant metastases refractory amenable establish treatment 4. evaluable tumour deposit 5. life expectancy least 3 month 6 . Eastern Cooperative Oncology Group ( ECOG ) performance score ≤ 2 7. patient must give write informed consent ( must consistent International Conference HarmonisationGood Clinical Practice ( ICHGCP ) local legislation ) 1. hypersensitivity humanise murine antibody , immunoconjugates excipients trial drug 2. know secondary malignancy require therapy 3. active infectious disease 4. brain metastasis require therapy 5. neuropathy grade 2 6. absolute neutrophil count less 1,500/mm3 7. platelet count less 100,000/mm3 8. bilirubin great 1.5 mg/dl ( &gt; 26 μmol/L , système internationale ( SI ) unit equivalent ) 9. aspartate amino transferase ( AST ) and/or alanine amino transferase ( ALT ) great 3 time upper limit normal 10. serum creatinine great 1.5 mg/dl ( &gt; 132 μmol/L , SI unit equivalent ) 11. concomitant nononcological disease consider relevant evaluation safety trial drug 12. chemo , radio immunotherapy within past four week prior treatment trial drug trial ( except present trial drug ) 13. men woman sexually active unwilling use medically acceptable method contraception 14. pregnancy lactation 15. treatment investigational drug participation another clinical trial within past four week start therapy concomitantly trial ( except present trial drug ) 16. patient unable comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>